Looking to collaborate?
What does your test detect?
What infection type does your test focus on?
What is the technological basis of your test?
About this entry
Embryyo is a medical technology startup company specializing in clinical need finding, inventing and commercializing novel medical devices. Our team comprises young and passionate engineers, designers, scientific, clinical and business advisors and extremely driven entrepreneurs with a vision to achieve global prosperity through good health and well-being. We intend to achieve our vision through breakthroughs in science, technology, research and design solving some of the toughest challenges in global health. We have been generously supported so far from the Gates Foundation and Department of Biotechnology, Govt. of India and are developing a strong portfolio of medical devices in the areas of public health, maternal and child health, interventional devices and life sciences.
Our test intends to distinguish between a bacterial or viral infection in samples of blood at a stage where the pathogen count is still very low to ascertain the presence of a pathogen at the early onset of the infection. The test also aims at counting the pathogen load from an infected blood sample. The test will be based on the direct capturing and entrapment of a pathogen cell using a combination of hydrodynamic and electrodynamic cell separation and load sensing techniques using microfluidic platforms. The test is intended to be label-free, and independent of any time-consuming amplification or sample preparation step, bringing the time of test to below 30 minutes.